George M Shaw

Q: What Schools Are Affiliated With George M Shaw

George M Shaw is affiliated with the following schools: University of Pennsylvania, University of Alabama at Birmingham, University of Alabama, Washington University in St. Louis, University of California, Berkeley, University of Cape Town, University of Nottingham, University of Oxford, Ohio State University, Stanford University

George M Shaw's AcademicInfluence.com Rankings

George M Shaw

Computer Science

#4865

World Rank

#5136

Historical Rank

Computational Linguistics

#559

World Rank

#568

Historical Rank

Machine Learning

#1094

World Rank

#1111

Historical Rank

Artificial Intelligence

#1324

World Rank

#1349

Historical Rank

computer-science Degrees

Download Badge

Computer Science

George M Shaw's Degrees

PhD Computer Science Stanford University
Masters Computer Science University of California, Berkeley
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is George M Shaw Influential?

(Suggest an Edit or Addition)

(See a Problem?)

George M Shaw's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Viral dynamics in human immunodeficiency virus type 1 infection (1995) (2904)
Antibody neutralization and escape by HIV-1 (2003) (2464)
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection (1994) (2011)
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection (2008) (1911)
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes (1999) (1806)
Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy (2002) (1573)
Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus (1997) (1339)
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. (1993) (1327)
AIDS as a zoonosis: scientific and public health implications. (2000) (1243)
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry (1998) (1011)
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus (2013) (940)
Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1 (2006) (912)
HTLV-III infection in brains of children and adults with AIDS encephalopathy. (1985) (857)
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS (1986) (784)
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection (2009) (781)
Sensitivity of Human Immunodeficiency Virus Type 1 to the Fusion Inhibitor T-20 Is Modulated by Coreceptor Specificity Defined by the V3 Loop of gp120 (2000) (745)
High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. (1991) (726)
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection (2009) (690)
Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV (1994) (680)
Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission (2004) (648)
Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing (2008) (624)
Acute HIV-1 Infection. (2011) (615)
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia (2008) (610)
Virus dynamics and drug therapy. (1997) (607)
HIV viral load markers in clinical practice (1996) (561)
Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. (1986) (559)
Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. (1984) (556)
Human infection by genetically diverse SIVSM-related HIV-2 in West Africa (1992) (518)
Origin of the human malaria parasite Plasmodium falciparum in gorillas (2010) (509)
Dynamics of HIV-1 recombination in its natural target cells (2004) (467)
Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions (1987) (430)
Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. (2009) (426)
Broad HIV-1 neutralization mediated by CD4-binding site antibodies (2007) (420)
Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors (2011) (420)
Extensive variation of human immunodeficiency virus type-1 in vivo (1988) (418)
The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin (1996) (391)
Phenotypic properties of transmitted founder HIV-1 (2013) (389)
Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes (1991) (387)
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology (1994) (387)
Human immunodeficiency viruses: SIV infection in wild gorillas (2006) (384)
Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C (2008) (369)
Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz (2009) (367)
Inflammatory Genital Infections Mitigate a Severe Genetic Bottleneck in Heterosexual Transmission of Subtype A and C HIV-1 (2009) (346)
Neutralizing Antibody Responses in Acute Human Immunodeficiency Virus Type 1 Subtype C Infection (2007) (336)
Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1 (2009) (332)
High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men (2010) (329)
Molecular cloning and characterization of the HTLV-III virus associated with AIDS (1984) (318)
Antigenic conservation and immunogenicity of the HIV coreceptor binding site (2005) (316)
Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of Their Replication Capacity in CD4 T Lymphocytes and Monocyte-Derived Macrophages (2011) (313)
Risk to Human Health from a Plethora of Simian Immunodeficiency Viruses in Primate Bushmeat (2002) (307)
A Comprehensive Panel of Near-Full-Length Clones and Reference Sequences for Non-Subtype B Isolates of Human Immunodeficiency Virus Type 1 (1998) (305)
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. (1997) (303)
Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing (2010) (297)
Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo (1992) (293)
Molecular biology of human T-lymphotropic retroviruses. (1985) (286)
Biologically diverse molecular variants within a single HIV-1 isolate (1988) (282)
Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations. (1997) (279)
Analysis of Neutralization Specificities in Polyclonal Sera Derived from Human Immunodeficiency Virus Type 1-Infected Individuals (2008) (278)
Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells (2002) (275)
Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants (2009) (270)
SIVcpz in wild chimpanzees. (2002) (264)
Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies (2014) (259)
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody (2016) (259)
Simian Immunodeficiency Virus Infection in Free-Ranging Sooty Mangabeys (Cercocebus atys atys) from the Taï Forest, Côte d'Ivoire: Implications for the Origin of Epidemic Human Immunodeficiency Virus Type 2 (2005) (247)
Determinants of Human Immunodeficiency Virus Type 1 Escape from the Primary CD8+ Cytotoxic T Lymphocyte Response (2004) (243)
Genomic diversity of human T-lymphotropic virus type III (HTLV-III). (1985) (230)
Mosaic genome structure of simian immunodeficiency virus from west African green monkeys. (1994) (230)
Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes. (1985) (222)
Constant Mean Viral Copy Number per Infected Cell in Tissues Regardless of High, Low, or Undetectable Plasma HIV RNA (1999) (220)
Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users (2010) (220)
An HIV-1 gp120 Envelope Human Monoclonal Antibody That Recognizes a C1 Conformational Epitope Mediates Potent Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity and Defines a Common ADCC Epitope in Human HIV-1 Serum (2011) (218)
Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways (2009) (214)
HIV transmission. (2012) (210)
Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants (2009) (207)
Endemic human T cell lymphotropic virus type II infection among isolated Brazilian Amerindians. (1992) (206)
Antigenicity and Immunogenicity of a Synthetic Human Immunodeficiency Virus Type 1 Group M Consensus Envelope Glycoprotein (2005) (205)
Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected Donors (2007) (204)
Velocity Distribution and Intimal Proliferation in Autologous Vein Grafts in Dogs (1978) (204)
Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys (2011) (204)
Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents. (2001) (197)
Species-specific diversity among simian immunodeficiency viruses from African green monkeys (1991) (194)
Relative resistance of HIV-1 founder viruses to control by interferon-alpha (2013) (192)
Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. (2012) (192)
HIV Evolution in Early Infection: Selection Pressures, Patterns of Insertion and Deletion, and the Impact of APOBEC (2009) (192)
Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected Individuals (2011) (190)
Early Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus Escape (2012) (188)
Antibody Specificities Associated with Neutralization Breadth in Plasma from Human Immunodeficiency Virus Type 1 Subtype C-Infected Blood Donors (2009) (186)
Simian Immunodeficiency Virus Infection of Chimpanzees (2005) (186)
African origin of the malaria parasite Plasmodium vivax (2014) (186)
Sensitivity of Human Immunodeficiency Virus Type 1 to Fusion Inhibitors Targeted to the gp41 First Heptad Repeat Involves Distinct Regions of gp41 and Is Consistently Modulated by gp120 Interactions with the Coreceptor (2001) (186)
Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies (2017) (176)
Modeling sequence evolution in acute HIV-1 infection. (2009) (175)
Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein. (1988) (175)
Evidence for Potent Autologous Neutralizing Antibody Titers and Compact Envelopes in Early Infection with Subtype C Human Immunodeficiency Virus Type 1 (2006) (174)
Envelope residue 375 substitutions in simian–human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques (2016) (174)
Polyclonal B Cell Differentiation and Loss of Gastrointestinal Tract Germinal Centers in the Earliest Stages of HIV-1 Infection (2009) (173)
Direct and Quantitative Single-Cell Analysis of Human Immunodeficiency Virus Type 1 Reactivation from Latency (2002) (172)
Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation (1992) (165)
Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: evidence for cross-species transmission in the wild (1994) (164)
Fitness Costs and Diversity of the Cytotoxic T Lymphocyte (CTL) Response Determine the Rate of CTL Escape during Acute and Chronic Phases of HIV Infection (2011) (156)
Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7 (2012) (154)
Quantifying the Diversification of Hepatitis C Virus (HCV) during Primary Infection: Estimates of the In Vivo Mutation Rate (2012) (152)
A Short-Term Clinical Evaluation of L-697,661, a Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase (1993) (151)
The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures (1995) (149)
Molecular Ecology and Natural History of Simian Foamy Virus Infection in Wild-Living Chimpanzees (2008) (147)
Phenotypic and Immunologic Comparison of Clade B Transmitted/Founder and Chronic HIV-1 Envelope Glycoproteins (2011) (146)
Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex. (1994) (145)
Origin and Biology of Simian Immunodeficiency Virus in Wild-Living Western Gorillas (2008) (143)
Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. (1996) (143)
Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections (2011) (139)
Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI (2010) (136)
Structure-Based Stabilization of HIV-1 gp120 Enhances Humoral Immune Responses to the Induced Co-Receptor Binding Site (2009) (136)
Human Papillomavirus DNA Replication Compartments in a Transient DNA Replication System (1999) (136)
Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge (2009) (134)
Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques (2015) (133)
Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. (1993) (131)
Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection (2007) (131)
Genomes of cryptic chimpanzee Plasmodium species reveal key evolutionary events leading to human malaria (2016) (130)
Foci of Endemic Simian Immunodeficiency Virus Infection in Wild-Living Eastern Chimpanzees (Pan troglodytes schweinfurthii) (2003) (129)
HIV-Host Interactions: Implications for Vaccine Design. (2016) (129)
High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels. (1991) (126)
Low-Dose Mucosal Simian Immunodeficiency Virus Infection Restricts Early Replication Kinetics and Transmitted Virus Variants in Rhesus Monkeys (2010) (125)
West African HIV-2-related human retrovirus with attenuated cytopathicity. (1988) (124)
Transfusion transmission of retroviruses: human T‐lymphotropic virus types I and II compared with human immunodeficiency virus type 1 (1994) (123)
Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice. (2003) (122)
Comparison of Viral Env Proteins from Acute and Chronic Infections with Subtype C Human Immunodeficiency Virus Type 1 Identifies Differences in Glycosylation and CCR5 Utilization and Suggests a New Strategy for Immunogen Design (2013) (119)
Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness (2017) (119)
Adaptation of HIV-1 to its human host. (2007) (118)
Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers (2019) (118)
Virus-Specific CD 8 + Cytotoxic T-Lymphocyte Activity Associated with Control of Viremia in Primary Human Immunodeficiency Virus Type 1 Infection (117)
New Simian Immunodeficiency Virus Infecting De Brazza's Monkeys (Cercopithecus neglectus): Evidence for a Cercopithecus Monkey Virus Clade (2004) (116)
An Isolate of Human Immunodeficiency Virus Type 1 Originally Classified as Subtype I Represents a Complex Mosaic Comprising Three Different Group M Subtypes (A, G, and I) (1998) (113)
HIV-1 Vpu Mediates HLA-C Downregulation. (2016) (110)
Broad Neutralization of Human Immunodeficiency Virus Type 1 Mediated by Plasma Antibodies against the gp41 Membrane Proximal External Region (2009) (110)
Limited sequence variation in human T-lymphotropic virus type 1 isolates from North American and African patients. (1991) (110)
Kinetics of Expansion of Epitope-Specific T Cell Responses during Primary HIV-1 Infection1 (2009) (108)
In Vivo gp41 Antibodies Targeting the 2F5 Monoclonal Antibody Epitope Mediate Human Immunodeficiency Virus Type 1 Neutralization Breadth (2009) (108)
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination. (2009) (107)
Ancestral and consensus envelope immunogens for HIV-1 subtype C. (2006) (106)
Origin of AIDS: Contaminated polio vaccine theory refuted (2004) (106)
High Prevalence of Simian Immunodeficiency Virus Infection in a Community of Savanna Chimpanzees (2011) (105)
Complementation of integrase function in HIV‐1 virions (1997) (104)
Scorpion-toxin mimics of CD4 in complex with human immunodeficiency virus gp120 crystal structures, molecular mimicry, and neutralization breadth. (2005) (103)
A Limited Number of Simian Immunodeficiency Virus (SIV) env Variants Are Transmitted to Rhesus Macaques Vaginally Inoculated with SIVmac251 (2010) (101)
Macrophage HIV‐1 infection and the gastrointestinal tract reservoir (2003) (101)
Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation. (2001) (101)
Unique Mutational Patterns in the Envelope α2 Amphipathic Helix and Acquisition of Length in gp120 Hypervariable Domains Are Associated with Resistance to Autologous Neutralization of Subtype C Human Immunodeficiency Virus Type 1 (2007) (101)
Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance. (2017) (99)
Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection. (1995) (97)
Induction of Plasma (TRAIL), TNFR-2, Fas Ligand, and Plasma Microparticles after Human Immunodeficiency Virus Type 1 (HIV-1) Transmission: Implications for HIV-1 Vaccine Design (2008) (96)
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers (2020) (92)
Immune thrombocytopenic purpura. Use of a 125I-labeled antihuman IgG monoclonal antibody to quantify platelet-bound IgG. (1983) (91)
Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication. (2015) (91)
HIV-Specific Functional Antibody Responses in Breast Milk Mirror Those in Plasma and Are Primarily Mediated by IgG Antibodies (2011) (91)
Selection Pressure on HIV-1 Envelope by Broadly Neutralizing Antibodies to the Conserved CD4-Binding Site (2012) (90)
Antigenicity and Immunogenicity of Transmitted/Founder, Consensus, and Chronic Envelope Glycoproteins of Human Immunodeficiency Virus Type 1 (2013) (90)
Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are the likely target cell for human immunodeficiency virus type 1 in the intestinal mucosa. (2000) (89)
Viral dynamics in primary HIV-1 infection (1993) (88)
Elucidation of Hepatitis C Virus Transmission and Early Diversification by Single Genome Sequencing (2012) (87)
Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies (2010) (86)
Transmitted/Founder and Chronic HIV-1 Envelope Proteins Are Distinguished by Differential Utilization of CCR5 (2012) (85)
Genomes of evolutionarily divergent members of the human T-cell leukemia virus family (HTLV-I and HTLV-II) are highly conserved, especially in pX. (1984) (84)
Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate (1990) (83)
Eastern Chimpanzees, but Not Bonobos, Represent a Simian Immunodeficiency Virus Reservoir (2012) (81)
B Cell Recognition of the Conserved HIV-1 Co-Receptor Binding Site Is Altered by Endogenous Primate CD4 (2008) (81)
A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. (1993) (81)
Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes. (1992) (80)
Human monocyte, lymphocyte, and granulocyte antibody-dependent cell-mediated cytotoxicity toward tumor cells. I. General characteristics of cytolysis. (1979) (80)
Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth (2018) (78)
Cross-Sectional Detection of Acute HIV Infection: Timing of Transmission, Inflammation and Antiretroviral Therapy (2011) (78)
Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins. (2007) (78)
Characterization of CFTR expression and chloride channel activity in human endothelia. (1998) (77)
Molecular cloning and analysis of a new variant of human T‐cell leukemia virus (HTLV‐Ib) from an African patient with adult T‐cell leukemia‐lymphoma (1984) (74)
Homology of genome of AIDS-associated virus with genomes of human T-cell leukemia viruses. (1984) (72)
Common Themes of Antibody Maturation to Simian Immunodeficiency Virus, Simian-Human Immunodeficiency Virus, and Human Immunodeficiency Virus Type 1 Infections (1998) (72)
Human Immunodeficiency Virus Type 2 (HIV-2)/HIV-1 Envelope Chimeras Detect High Titers of Broadly Reactive HIV-1 V3-Specific Antibodies in Human Plasma (2008) (72)
Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection (2018) (70)
Origin and Evolution of HIV-1 in Breast Milk Determined by Single-Genome Amplification and Sequencing (2010) (70)
Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIVMAC (1988) (69)
Amplification of a Complete Simian Immunodeficiency Virus Genome from Fecal RNA of a Wild Chimpanzee (2003) (69)
Individuals infected with HIV possess antibodies against IL-2. (1988) (69)
Mucosal Simian Immunodeficiency Virus Transmission in African Green Monkeys: Susceptibility to Infection Is Proportional to Target Cell Availability at Mucosal Sites (2012) (68)
Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-Ib) provirus with a deletion in pX-I (1985) (68)
Cytotoxic T‐lymphocyte escape viral variants: how important are they in viral evasion of immune clearance in vivo? (1998) (67)
Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection. (2018) (66)
Human monocyte antibody-dependent cell-mediated cytotoxicity to tumor cells. (1978) (65)
Determinants of Human Immunodeficiency Virus Type 1 Baseline Susceptibility to the Fusion Inhibitors Enfuvirtide and T-649 Reside outside the Peptide Interaction Site (2004) (65)
Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones. (2013) (65)
Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components. (1993) (65)
Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses. (2015) (65)
A Signature in HIV-1 Envelope Leader Peptide Associated with Transition from Acute to Chronic Infection Impacts Envelope Processing and Infectivity (2011) (63)
Broad and Potent Neutralizing Antibody Responses Elicited in Natural HIV-2 Infection (2011) (62)
Human immunodeficiency virus type 2 vpx protein augments viral infectivity. (1991) (62)
Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity (2015) (62)
Generation of Infectious Molecular Clones of Simian Immunodeficiency Virus from Fecal Consensus Sequences of Wild Chimpanzees (2007) (61)
Plasmodium falciparum-like parasites infecting wild apes in southern Cameroon do not represent a recurrent source of human malaria (2013) (60)
Determination of plasma viral load in HIV‐1 infection by quantitative competitive polymerase chain reaction (1993) (60)
Relation of HTLV-4 to simian and human immunodeficiency-associated viruses (1987) (59)
Human monocyte cytotoxicity to tumor cells. I. Antibody-dependent cytotoxicity. (1978) (58)
Association of strong virus-specific CD4 T cell responses with efficient natural control of primary HIV-1 infection (2004) (58)
Primary Infection by a Human Immunodeficiency Virus with Atypical Coreceptor Tropism (2011) (57)
Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome (2012) (56)
Genetic variants of human T-lymphotrophic virus type II in American Indian groups. (1996) (56)
Intestinal macrophages display reduced permissiveness to human immunodeficiency virus 1 and decreased surface CCR5. (1999) (55)
A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge. (2019) (55)
Infection of gastrointestinal tract macrophages by HIV‐1 (1997) (55)
Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein. (2008) (54)
Functional Analysis of the Simian Immunodeficiency Virus Vpx Protein: Identification of Packaging Determinants and a Novel Nuclear Targeting Domain (2001) (53)
Widely varying SIV prevalence rates in naturally infected primate species from Cameroon. (2006) (51)
Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients (2015) (49)
Simian Immunodeficiency Virus Infection in Wild-Caught Chimpanzees from Cameroon (2005) (48)
Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection (2017) (47)
Noninvasive detection of Simian immunodeficiency virus infection in a wild-living L'Hoest's monkey (Cercopithecus Ihoesti). (2003) (47)
Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteins. (2014) (47)
Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability (2016) (47)
Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses (2017) (45)
A full-length and replication-competent proviral clone of SIVAGM from tantalus monkeys. (1997) (45)
HIV-1 sequence subtype D in the United States. (1994) (44)
Neutralizing IgG at the Portal of Infection Mediates Protection against Vaginal Simian/Human Immunodeficiency Virus Challenge (2013) (42)
Unsuspected primary human immunodeficiency virus type 1 infection in seronegative emergency department patients. (1994) (42)
Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants (2013) (42)
Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection (2016) (42)
Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection. (2000) (42)
Multigenomic Delineation of Plasmodium Species of the Laverania Subgenus Infecting Wild-Living Chimpanzees and Gorillas (2016) (41)
Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies (2021) (41)
4E10-Resistant Variants in a Human Immunodeficiency Virus Type 1 Subtype C-Infected Individual with an Anti-Membrane-Proximal External Region-Neutralizing Antibody Response (2007) (41)
Biological parameters of HIV‐1 infection in primary intestinal lymphocytes and macrophages (2000) (41)
Characterization of CFTR expression and chloride channel activity in human endothelia. (1998) (40)
Emergence of Individuality in Genetically Identical Mice (2013) (40)
Human T-cell leukemia virus: its discovery and role in leukemogenesis and immunosuppression. (1984) (40)
Wild bonobos host geographically restricted malaria parasites including a putative new Laverania species (2017) (40)
Heterogeneity in Neutralization Sensitivities of Viruses Comprising the Simian Immunodeficiency Virus SIVsmE660 Isolate and Vaccine Challenge Stock (2013) (39)
The acute retroviral syndrome and the pathogenesis of HIV-1 infection. (1993) (39)
Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared. (1995) (39)
Autologous Neutralizing Antibodies to the Transmitted/Founder Viruses Emerge Late after Simian Immunodeficiency Virus SIVmac251 Infection of Rhesus Monkeys (2010) (38)
Quantification of platelet-bound IgG by 125I-Staphylococcal protein A in immune thrombocytopenic purpura and other thrombocytopenic disorders. (1984) (38)
Predictors of Nonseroconversion after SARS-CoV-2 Infection (2021) (38)
Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1. (2010) (37)
Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth (2020) (37)
Transfusion of blood components from a donor with human T-lymphotropic virus type II (HTLV-II) infection. The Transfusion Safety Study Group. (1990) (36)
Contribution of proteasome-catalyzed peptide cis-splicing to viral targeting by CD8+ T cells in HIV-1 infection (2019) (36)
Human lymphocyte, monocyte, and neutrophil antibody-dependent cell-mediated cytotoxicity toward human erythrocytes. (1978) (36)
Determination of a unique and immunodominant epitope of human T cell lymphotropic virus type I. (1990) (35)
Bis-Anthracycline Antibiotics Inhibit Human Immunodeficiency Virus Type 1 Transcription (2004) (35)
Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II. (1991) (34)
Type-specific antigens for serological discrimination of HTLV-I and HTLV-II infection (1990) (33)
Distinct Evolutionary Pressures Underlie Diversity in Simian Immunodeficiency Virus and Human Immunodeficiency Virus Lineages (2012) (33)
Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption (2021) (33)
Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB). (1994) (32)
Spontaneous lymphocyte proliferation in HTLV-II infection (1991) (32)
Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline (2008) (30)
Human lymphocyte antibody-dependent cell-mediated cytotoxicity (ADCC) toward human red blood cells. (1978) (28)
Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length (2015) (28)
Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge. (2020) (27)
A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays. (2010) (27)
Concordant induction of cyclin E and p21cip1 in differentiated keratinocytes by the human papillomavirus E7 protein inhibits cellular and viral DNA synthesis. (1999) (27)
Effects of tapering doses of oral prednisone on viral load among HIV-infected patients with unexplained weight loss. (1997) (26)
Complete genome analysis of one of the earliest SIVcpzPtt strains from Gabon (SIVcpzGAB2). (2004) (26)
Epitope Mapping of Broadly Neutralizing HIV-2 Human Monoclonal Antibodies (2012) (26)
Chronic HIV infection affects the expression of the 2 transcription factors required for CD8 T-cell differentiation into cytolytic effectors. (2012) (25)
HTLV-III and the etiology of AIDS. (1986) (24)
The etiology of AIDS. (1985) (24)
Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes. (2015) (24)
Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques (2016) (23)
Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants (2015) (23)
Neutralization Properties of Simian Immunodeficiency Viruses Infecting Chimpanzees and Gorillas (2015) (22)
Mother-to-infant transmission of the human immunodeficiency virus during primary infection. (1999) (22)
Simian-Human Immunodeficiency Virus SHIV.CH505 Infection of Rhesus Macaques Results in Persistent Viral Replication and Induces Intestinal Immunopathology (2019) (22)
Single-Genome Sequencing of Hepatitis C Virus in Donor-Recipient Pairs Distinguishes Modes and Models of Virus Transmission and Early Diversification (2015) (20)
High throughput drug screening for human immunodeficiency virus type 1 reactivating compounds. (2007) (20)
Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4 (2015) (20)
Transmission of human T‐lymphotropic virus type I by blood components from a donor lacking anti‐p24: a case report (1992) (19)
SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques (2020) (19)
gp120-mediated alterations in astrocyte ion transport. (1994) (19)
Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque Controllers (2016) (18)
Clustered IgG on human red blood cell membranes may promote human lymphocyte antibody-dependent cell-mediated cytotoxicity. (1980) (18)
Primary HIV-1 infection. (1991) (18)
CD154-CD40-induced reactivation of latent HIV-1 infection. (2003) (18)
Derivation and Characterization of Pathogenic Transmitted/Founder Molecular Clones from Simian Immunodeficiency Virus SIVsmE660 and SIVmac251 following Mucosal Infection (2016) (17)
Molecular characterization of a highly divergent HIV type 1 isolate obtained early in the AIDS epidemic from the Democratic Republic of Congo. (2001) (17)
Amphotericin-B-mediated reactivation of latent HIV-1 infection. (2005) (17)
Localization of HuC (ELAVL3) to chromosome 19p13.2 by fluorescence in situ hybridization utilizing a novel tyramide labeling technique. (1998) (17)
Transmitted/Founder Hepatitis C Viruses Induce Cell-Type- and Genotype-Specific Differences in Innate Signaling within the Liver (2015) (16)
Re-examination of the EA rosette assay (Ripley) for Fc receptor leucocytes. (1979) (16)
Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence (2018) (16)
CD4 receptor diversity in chimpanzees protects against SIV infection (2019) (15)
Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users (2014) (15)
Simian-Human Immunodeficiency Virus SHIV.CH505-Infected Infant and Adult Rhesus Macaques Exhibit Similar Env-Specific Antibody Kinetics, despite Distinct T-Follicular Helper and Germinal Center B Cell Landscapes (2019) (15)
Fitness costs and diversity of CTL response determine the rate of CTL escape during the acute and chronic phases of HIV infection (105.23) (2011) (15)
Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes (2019) (14)
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies (2022) (14)
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection (2021) (14)
Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque Model (2019) (13)
Lack of viral latency of human T-cell lymphotropic virus type I. (1991) (13)
Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4+ T Cells (2020) (13)
Molecular mechanisms of HIV type 1 prophylaxis failure revealed by single-genome sequencing. (2013) (12)
Innate immune responses in acute HIV-1 infection: protective or pathogenic? (2013) (12)
Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeys. (2022) (11)
Feasibility of developing live attenuated HIV vaccines: conclusions and recommendations. World Health Organization Working Group. (1994) (11)
New SHIVs and Improved Design Strategy for Modeling HIV-1 Transmission, Immunopathogenesis, Prevention and Cure (2021) (11)
Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis (2013) (11)
Single genome amplification and direct amplicon sequencing of Plasmodium spp. DNA from ape fecal specimens. (2010) (11)
Human T-lymphotropic virus type I-associated myelopathy in patients with the acquired immunodeficiency syndrome. (1992) (10)
High multiplicity infection following transplantation of hepatitis C virus-positive organs. (2019) (9)
Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee (2017) (9)
erratum: Antibody neutralization and escape by HIV-1 (2003) (8)
Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates (2021) (8)
Dissecting the neutralizing antibody specificities of broadly neutralizing sera from 1 HIV-1 infected donors 2 * (2007) (7)
Corrigendum to “Modeling sequence evolution in acute HIV-1 infection” [J. Theor. Biol. 261 (2009) 341–360] (2012) (7)
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers (2020) (7)
Molecular characterization of human T-lymphotropic leukemia virus type III associated with the acquired immunodeficiency syndrome. (1984) (7)
Human T‐Cell Lymphotropic Virus Infection among Blood Donors in South Florida (1991) (6)
Assessing routes of hepatitis C transmission in HIV-infected men who have sex with men using single genome sequencing (2020) (6)
Erratum: Dynamics of HIV-1 recombination in its natural target cells (Proceedings of the National Academy of Sciences (March 2004) 101:12 (4204-4209)) (2005) (6)
Differential Outcomes following Optimization of Simian-Human Immunodeficiency Viruses from Clades AE, B, and C (2020) (5)
SHIV.CH505-infected infant and adult rhesus macaques exhibit similar HIV Env-specific antibody kinetics, despite distinct T-follicular helper (Tfh) and germinal center B cell landscapes (2019) (5)
Small CD 4 Mimetics Prevent HIV-1 Uninfected Bystander CD 4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity (2016) (5)
Estimating the Timing of Early Simian-Human Immunodeficiency Virus Infections: a Comparison between Poisson Fitter and BEAST (2020) (5)
Human Monocyte Antibody-Dependent Cell-Mediated (1978) (5)
A Plea for Justice for Jailed Medical Workers (2006) (5)
Zoonotic origin of the human malaria parasite Plasmodium malariae from African apes (2022) (4)
Human T‐Cell Lymphotropic Virus Type I and II (2003) (4)
New SHIVs and Improved Design Strategy for Modeling HIV-1 Transmission, Immunopathogenesis, Prevention, and Cure (2021) (4)
CD4 receptor diversity represents an ancient protection mechanism against primate lentiviruses (2021) (4)
Nucleotide Sequence Analysis of a Variant Human T-Cell Leukemia Virus ( HTLV-Ib ) Provirus with a Deletion in pXI (3)
Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques (2021) (3)
Escape is a more common mechanism than avidity reduction for evasion of CD8+ T cell responses in primary human immunodeficiency virus type 1 infection (2011) (3)
Correction: Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection (2017) (3)
Oral clade C SHIV challenge models to study pediatric HIV-1 infection by breastmilk transmission (2019) (3)
Dynamics and origin of rebound viremia in SHIV-infected infant macaques following interruption of long-term ART (2021) (3)
Vaccine-induced protection from homologous Tier 2 simian-human immunodeficiency virus challenge in nonhuman primates (2018) (3)
Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infection (2022) (3)
Nucleotide Sequence Analysis of a Variant Human T-Cell Leukemia Virus ( HTLV-Ib ) Provirus with a Deletion in pXI (3)
Conformational Epitope Mediates Potent ADCC Activity and Defines a Common 2 (2011) (3)
Fab-dimerized glycan-reactive antibodies neutralize HIV and are prevalent in humans and rhesus macaques (2020) (3)
Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency (2022) (3)
HCV Infection Induces Autocrine Interferon Signaling by Human Liver Endothelial Cell and Release of Exosomes, Which Inhibits Viral Replication (2016) (3)
Molecular Identification of Transmitted/Founder Hepatitis C Viruses and Their Progeny by Single Genome Sequencing. (2018) (3)
Enhanced Ability of Plant-Derived PGT121 Glycovariants To Eliminate HIV-1-Infected Cells (2021) (3)
The Role of the Astrocyte in the Pathogenesis of the AIDS Dementia Complex (1995) (2)
394 – Biology of Human Immunodeficiency Viruses (2012) (2)
Edinburgh Research Explorer Simian immunodeficiency virus infection in free-ranging sooty Mangabeys (Cercocebus atys atys) from the Tai Forest, Cote (2005) (2)
Immune responses and viral persistence in SHIV.C.CH848-infected rhesus macaques. (2021) (2)
Correction: Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability (2016) (2)
Human T-cell lymphotropic virus infection among blood donors in south Florida. The Transfusion Safety Study Group. (1991) (2)
Evidence for Potent Autologous Neutralizing Antibody Titers and Compact Envelopes in Early Infection with Subtype C Human Immunodeficiency Virus Type 1 (2007) (2)
Incident cases characterization and deep sequencing provide new insight into multiplicity of infection and HIV evolution in very early acute infection (2012) (2)
Temporal Aspects Of Hiv Dna And Rna Synthesis And Tissue Distribution During Hiv Infection (1993) (1)
Response : HIV and AIDS (1993) (1)
Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis (2013) (1)
Relative resistance of HIV-1 founder viruses to control by interferon-alpha (2013) (1)
Human Monocyte Cytotoxicity to Tumor Cells (1978) (1)
Molecular cloning and analysis of different human t lymphotropic retroviruses from patients with acquired immune deficiency syndrome or t cell malignancy (1984) (1)
Nucleotide, Protein Evidence of two distinc subsubtypes within the HIV-1 subtype A radiation (2001) (1)
Distinct Evolutionary Pressures Underlie Diversity in Simian and (2012) (1)
Molecular biology of HIV-1 in AIDS dementia complex (1992) (1)
Assignment1 of human MFNG, manic fringe Drosophila homolog, to 22q13.1 using tyramide fluorescence in situ hybridization (T-FISH) (1999) (1)
HTLV-III and the Etiology of AIDS (Part 2 of 2) (1986) (1)
Molecular identification of transmitted/founder viruses by single genome amplification following percutaneous occupational exposure to HIV-1 (2010) (1)
Analysis of Neutralization Speciﬁcities in Polyclonal Sera Derived from Human Immunodeﬁciency Virus Type 1-Infected Individuals (cid:1) (2008) (1)
116 Autologous and Heterologous Neutralizing Antibody Responses in HIV-1 Infection (2012) (1)
Detection of Novel Neutralizing Antibody Reactivities Against The Membrane Proximal External Region (MPER) of gp41 in HIV-1 Infected Humans (2005) (1)
Etiology of AIDS: biological and biochemical characteristics of HTLV-III. (1985) (1)
Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome (2012) (1)
Simian Immunodeficiency Virus Infection in Free-Ranging Sooty Mangabeys (Cercocebus atys atys) from the Taï Forest, Côte d'Ivoire: Implications for the Origin of Epidemic Human Immunodeficiency Virus Type 2 (2006) (1)
Inhibition of Protein Degradation in Mouse Hearts by Agents That Cause Lysosomal Dysfunction (2005) (1)
Recombinant virus coat protein associated with "Acquired Immune Deficiency Syndrome" (AIDS), and methods for testing of AIDS. (1986) (1)
Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection (2018) (0)
Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants (2013) (0)
A meta-analysis of passive immunization studies shows an association of serum neutralizing antibody titer with protection against SHIV challenge (2019) (0)
Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1 (2022) (0)
Importance of Primer selection and PCR amplification in Estimating HIV viral variation using traditional and 454 FLX sequencing (2011) (0)
Researchenhancement of HIV infection is donor-dependent and correlates with the levels of SEVI (2010) (0)
Potent Anti-Viral Activity of a Trispecific HIV Antibody in SHIV-Infected Monkeys (2021) (0)
Human Immunodeﬁciency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection (cid:1) (2007) (0)
Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee (2017) (0)
Edinburgh Research Explorer Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees sequences (2018) (0)
C106 Distinguishing Features of Transmitted/Founder HIV-1 (2013) (0)
Cyclosporin A (1995) (0)
2761 – A NEW ASSAY FOR ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY (ADCC) BY HUMAN LYMPHOCYTES (Ly), MONOCYTES (Mo) AND NEUTROPHILS (Ne) (1978) (0)
Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1 (2022) (0)
Efficient ex vivo expansion of conserved element vaccine-specific CD8+ T-cells from SHIV-infected, ART-suppressed nonhuman primates (2023) (0)
HTLV-III and the Etiology of AIDS (Part 1 of 2) (1986) (0)
108 Identification of Full-length Transmitted HIV-1 Genomes Reveals Extraordinary Dynamics and Precise Molecular Pathways of Early Virus Diversification, Adaptation and Immune Evasion (2009) (0)
Genetic Variation of HIV: Viral Load and Genotypic Diversity in Relation to Viral Pathogenesis and Treatment (1993) (0)
ANALYSIS OF THE ANTIVIRAL CYTOTOXIC T-LYMPHOCYTE RESPONSE IN PRIMARY HIV-1 (1995) (0)
Studies of Genetic Variation in the AIDS Virus: Relevance to Disease Pathogenesis Anti-Viral Therapy, and Vaccine Development (1990) (0)
Correction for Rudicell et al., “High Prevalence of Simian Immunodeficiency Virus Infection in a Community of Savanna Chimpanzees” (2022) (0)
Parasite to Prevention: Advances in the understanding of malaria (2010) (0)
Response : Effect of Platelet-Associated Virus on Assays of HIV-1 in Plasma (1993) (0)
Human leukocyte antibody-dependent cell-mediated cytotoxicity : demonstration of lymphocyte, monocyte, and neutrophil-mediated lysis of allogeneic erthrocytes and tumor cells / (1979) (0)
Contributors (2012) (0)
Limited acute CTL escape among three founder viruses in a case of acute heterosexual transmission of HIV-1 infections (2011) (0)
Analysis of the Relationship Between Founder Virus Fitness, Primary T Cell Response Breadth and Viral Control in Acute HIV-1 Infection (2013) (0)
Wild bonobos host geographically restricted malaria parasites including a putative new Laverania species (2017) (0)
Corrigendum to: Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes [Virology 475 (2015) 37–45] (2015) (0)
Edinburgh Research Explorer A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1 (1998) (0)
Recognition of Hepatitis C Virus Transmitted / founder 1 Variants by RIGI is dependent on U-Core length 2 3 4 (2015) (0)
Differential Utilization of CCR5 Envelope Proteins Are Distinguished by Transmitted/Founder and Chronic HIV-1 (2014) (0)
Correction for Sharp et al., “Simian Immunodeficiency Virus Infection of Chimpanzees” (2022) (0)
J. Virol.-2011-Jiang-10669-81 (2012) (0)
Generation of Infectious Molecular Clones of Simian Immunodeﬁciency Virus from Fecal Consensus Sequences of Wild Chimpanzees (cid:1) (2007) (0)
Erratum: Limited sequence variation in human T-lymphotropic virus type 1 isolates from North American and African patients (Virology (1991) 182 (111- 123)) (1992) (0)
Giemsa Staining of Chromosomes in Root Tip Cells (1975) (0)
Mechanism of leukemogenesis by human T-cell leukemia virus types I and II: role of the lor gene. (1987) (0)
The Role of T Cell Immunity in the Control of HIV Infection (2010) (0)
Crystal structure of [Phe23]M47, a scorpion-toxin mimic of CD4, in complex with HIV-1 YU2 GP120 envelope glycoprotein and anti-HIV-1 antibody 17B (2005) (0)
Dissecting the Neutralizing Antibody Speciﬁcities of Broadly Neutralizing Sera from Human Immunodeﬁciency Virus Type 1-Infected Donors (cid:1) (2007) (0)
The Family of Human T-Cell Leukemia Viruses and Their Role in the Cause of T-Cell Leukemia and AIDS (1985) (0)
A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies (2022) (0)
Persistent plasma viremia in acute and early chronic HIV-1 infection Implications for natural history and pathogenesis (1993) (0)
Analytical treatment interruption after short-term anti-retroviral therapy in a postnatally SHIV infected infant rhesus macaque model (2019) (0)
T.59. The Composition of the Primary Immunoglobulin Repertoire Influences HIV gp140 Epitope Selection (2009) (0)
Strategy for Immunogen Design CCR 5 Utilization and Suggests a New Identifies Differences in Glycosylation and C Human Immunodeficiency Virus Type 1 Acute and Chronic Infections with Subtype Comparison of Viral Env Proteins from (2013) (0)
Heightened resistance to type 1 interferons characterizes HIV-1 at transmission and following analytical treatment interruption (2020) (0)
Quantitative Assessment of HIV Replication and Variation In Vivo: Relevance to Disease Pathogenesis and Response to Therapy. (1994) (0)
Virus Reservoir Represent a Simian Immunodeficiency Eastern Chimpanzees, but Not Bonobos, (2012) (0)
Lymphocytes, not macrophages, are the primary target cell for HIV-1 in human intestinal mucosa (2000) (0)
The human T-cell leukemia virus family, adult T cell leukemia, and AIDS. (1985) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With George M Shaw?

George M Shaw is affiliated with the following schools:

George M Shaw's Academic­Influence.com Rankings

George M Shaw's Degrees

Similar Degrees You Can Earn

Why Is George M Shaw Influential?

George M Shaw's Published Works

Published Works

What Schools Are Affiliated With George M Shaw?

George M Shaw's AcademicInfluence.com Rankings